230 filings
8-K
ADCT
Adc Therapeutics SA
14 May 24
Corporate Presentation 2Q 2024
12:32pm
8-K
ADCT
Adc Therapeutics SA
8 May 24
Other Events
4:07pm
424B5
ADCT
Adc Therapeutics SA
7 May 24
Prospectus supplement for primary offering
4:02pm
424B5
ADCT
Adc Therapeutics SA
6 May 24
Prospectus supplement for primary offering
6:51am
10-Q
2024 Q1
ADCT
Adc Therapeutics SA
6 May 24
Quarterly report
6:38am
8-K
sc5v71kti8617n
6 May 24
ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
6:29am
DEFA14A
j302uoc00ut zo2
26 Apr 24
Additional proxy soliciting materials
4:21pm
DEF 14A
njvhw8bjd4q2r 2b
26 Apr 24
Definitive proxy
4:05pm
PRE 14A
durhrbqy471 4moj9o2x
16 Apr 24
Preliminary proxy
4:16pm
8-K
t2wj6pj2
9 Apr 24
3 Agenda ▪ Business Update ▪ Our Research Strategy ▪ Our Platform ▪ Lead Candidates ▪ Forward Looking ▪ Closing Remarks ▪ Q&A
4:06pm
424B3
cvvmc
15 Mar 24
Prospectus supplement
4:11pm
424B3
v26hi8wk5h6chpsx
15 Mar 24
Prospectus supplement
4:11pm
EFFECT
nvh1l4pzemtxu93fe8
15 Mar 24
Notice of effectiveness
12:15am
EFFECT
pu70rjasvz
15 Mar 24
Notice of effectiveness
12:15am
EFFECT
iwsm8g 7t
15 Mar 24
Notice of effectiveness
12:15am
POS AM
jx5l1vgi9u
13 Mar 24
Prospectus update (post-effective amendment)
4:17pm
POS AM
4k1 his7hi0b
13 Mar 24
Prospectus update (post-effective amendment)
4:16pm
POS AM
6qa96lu29w2s5g 2ssb
13 Mar 24
Prospectus update (post-effective amendment)
4:14pm
ARS
4317q1an 5cznn4x72
13 Mar 24
Annual report to shareholders
3:19pm
10-K
p3ea4a6yt3lkoxrw
13 Mar 24
Annual report
12:25pm